The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Don’t blame you as I have added too. The current price is a bargain for what will be a successful trial outcome. At least that is what I personally believe and the testing by SBTX to date suggests the same I believe.
I think breakout is very close now. Will it need some news though?
Yes I agree things are certainly looking positive here. Indeed, I have topped up twice today and will look to add further. This appointment is a real plus for AVCT. Moreover, we have our test coming on line very soon. I can see AVCT becoming a major player in due course.
You may need to take another look at the stats. Nearly 80% success rate. I am not a scientist but I know people who are and they are excited about these results. The report from Bradford earlier today is an example of the treatment working. I think the next steps will be very interesting.